Download presentation
Presentation is loading. Please wait.
Published byLisa Ferraro Modified over 5 years ago
1
Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer
Shona Hendry, M.B.B.S., David J. Byrne, BSc, Gavin M. Wright, PhD, Richard J. Young, MSc, Sue Sturrock, BSc, Wendy A. Cooper, PhD, Stephen B. Fox, DPhil Journal of Thoracic Oncology Volume 13, Issue 3, Pages (March 2018) DOI: /j.jtho Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
2
Figure 1 Representative tumor microarray core stained with the programmed death ligand 1 immunohistochemical assays 22C3, 28-8, SP142, and SP263. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
3
Figure 2 (A) Tumor cell scores for each programmed death ligand 1 immunohistochemical assay. (B) Immune cell scores for each programmed death ligand 1 immunohistochemical assay. Cases with no staining by all four antibodies are not shown. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
4
Figure 3 Scatter plots showing pairwise comparisons of the percentage tumor cell staining between the four programmed death ligand 1 immunohistochemical assays (N = 355), including regression line with 95% confidence intervals. Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.